Molecular, Biochemical, and Clinical Characterization of Thirteen Patients with Glycogen Storage Disease 1a in Malaysia
Open Access
- 13 September 2022
- journal article
- research article
- Published by Wiley in Genetics Research
- Vol. 2022, 1-7
Abstract
Molecular, Biochemical, and Clinical Characterization of Thirteen Patients with Glycogen Storage Disease 1a in Malaysia: Background. Glycogen storage disease type 1a (GSD1a) is a rare autosomal recessive metabolic disorder characterized by hypoglycaemia, growth retardation, lactic acidosis, hepatomegaly, hyperlipidemia, and nephromegaly. GSD1a is caused by a mutation in the G6PC gene encoding glucose-6-phosphatase (G6Pase); an enzyme that catalyses the hydrolysis of glucose-6-phosphate (G6P) to phosphate and glucose. Objective. To elaborate on the clinical findings, biochemical data, molecular genetic analysis, and short-term prognosis of 13 GSD1a patients in Malaysia. Methods. The information about 13 clinically classified GSD1a patients was retrospectively studied. The G6PC mutation analysis was performed by PCR-DNA sequencing. Results. Patients were presented with hepatomegaly (92), hypoglycaemia (38), poor weight gain (23), and short stature (15). Mutation analysis revealed nine heterozygous mutations; eight previously reported mutations (c.155A>T, c.209G>A, c.226A>T, c.248G>A, c.648G>T, c.706T>A, c.1022T>A, c.262delG) and a novel mutation (c.325T>C). The most common mutation found in Malaysian patients was c.648G>T in ten patients (77) of mostly Malay ethnicity, followed by c.248G>A in 4 patients of Chinese ethnicity (30). A novel missense mutation (c.325T>C) was predicted to be disease-causing by various in silico software. Conclusions. The establishment of G6PC molecular genetic testing will enable the detection of presymptomatic patients, assisting in genetic counselling while avoiding the invasive methods of liver biopsy.Keywords
This publication has 33 references indexed in Scilit:
- Glucose-6-phosphatase deficiencyOrphanet Journal of Rare Diseases, 2011
- Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapyNature Reviews Endocrinology, 2010
- Mutations in the glucose-6-phosphatase-α (G6PC) gene that cause type Ia glycogen storage diseaseHuman Mutation, 2008
- Glycogen storage disease type Ia in Argentina: two novel glucose-6-phosphatase mutations affecting protein stabilityMolecular Genetics and Metabolism, 2004
- The glycogen storage diseasesCurrent Paediatrics, 2004
- Mutation spectrum of the glucose‐6‐phosphatase gene and its implication in molecular diagnosis of Korean patients with glycogen storage disease type IaClinical Genetics, 2004
- A Glucose-6-phosphate Hydrolase, Widely Expressed Outside the Liver, Can Explain Age-dependent Resolution of Hypoglycemia in Glycogen Storage Disease Type IaJournal of Biological Chemistry, 2003
- Exon redefinition by a point mutation within exon 5 of the glucose-6-phosphatase gene is the major cause of glycogen storage disease type 1a in JapanHepatology, 1995
- Identification of mutations in the gene for glucose-6-phosphatase, the enzyme deficient in glycogen storage disease type 1a.Journal of Clinical Investigation, 1994
- Mutations in the Glucose-6-Phosphatase Gene that Cause Glycogen Storage Disease Type 1aScience, 1993